Advertisement
Home »

Results of a randomised Phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer.

Jan 22, 2024

ABOUT THE EXPERTS

  • Shibani Nicum

    University College London Cancer Institute, London, UK. s.nicum@ucl.ac.uk.

    Naomi McGregor

    Newcastle Clinical Trials Unit, Newcastle University, UK and Oncology Clinical Trials Office (OCTO), Department of Oncology, University of Oxford, Oxford, UK.

    Rachel Austin

    Oncology Clinical Trials Office (OCTO), Department of Oncology, University of Oxford, Oxford, UK.

    Linda Collins

    Oncology Clinical Trials Office (OCTO), Department of Oncology, University of Oxford, Oxford, UK.

    Susan Dutton

    Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.

    Iain McNeish

    Ovarian Cancer Action Research Centre Department of Surgery and Cancer, Imperial College London, London, UK.

    Rosalind Glasspool

    Beatson West of Scotland Cancer Centre, NHS Greater Glasgow and Clyde and University of Glasgow, Glasgow, UK.

    Marcia Hall

    Department of Medical Oncology, Mount Vernon Cancer Centre, Middlesex, Northwood, UK.

    Rene Roux

    Department of Oncology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

    Agnieszka Michael

    Department of Clinical and Experimental Medicine, University of Surrey, Surrey, UK.

    Andrew Clamp

    The Christie NHS Foundation Trust and Institute of Cancer Sciences, University of Manchester, Manchester, UK.

    Gordon Jayson

    The Christie NHS Foundation Trust and Institute of Cancer Sciences, University of Manchester, Manchester, UK.

    Rebecca Kristeleit

    Guy’s and St Thomas NHS Foundation Trust and King’s College London, London, UK.

    Susana Banerjee

    The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, UK.

    Anita Mansouri

    Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement